Antigen presenting cell-selective drug delivery by glycan-decorated nanocarriers

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 95, Issue , 2015, Pages 13-17

  Frenz, Theresa ^a   Grabski, Elena ^a   Durán, Verónica ^a   Hozsa, Constantin ^b   Stępczyńska, Anna ^b   Furch, Marcus ^b   Gieseler, Robert K ^b   Kalinke, Ulrich ^a  

^a INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^b Rodos BioTarget GmbH   (Germany)

Author keywords

Antigen presenting cells; C type lectin receptor; Dendritic cells; Glycan functionalized liposomes; Nanocarrier; Targeting of subcellular compartments

Indexed keywords

C TYPE LECTIN RECEPTOR; CD209 ANTIGEN; GLYCAN; LECTIN RECEPTOR; LIPOSOME; MANNOSE RECEPTOR; MANNOSE RECEPTOR C TYPE 1; UNCLASSIFIED DRUG; DRUG CARRIER; NANOSPHERE; POLYSACCHARIDE;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SELECTIVITY; ENDOCYTOSIS; HUMAN; MACROPHAGE; MONOCYTE; MYELOID DENDRITIC CELL; PATHOGENESIS; PROTEIN EXPRESSION; TARGET CELL; ANIMAL; DENDRITIC CELL; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; PHAGOCYTOSIS; PHYSIOLOGY; PROCEDURES; TRENDS;

ANIMALS; ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; MACROPHAGES; NANOSPHERES; PHAGOCYTOSIS; POLYSACCHARIDES;

EID: 84944280036     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2015.02.008     Document Type: Article

References (74)

1. D. Singh, S. Singh, J. Sahu, S. Srivastava, and M.R. Singh Ceramic nanoparticles: recompense, cellular uptake and toxicity concerns Artificial Cells, Nanomed. Biotechnol. 2014 1 9
2. G. Lambert, E. Fattal, and P. Couvreur Nanoparticulate systems for the delivery of antisense oligonucleotides Adv. Drug Deliv. Rev. 47 2001 99 112
3. F. Mohamed, and C.F. van der Walle Engineering biodegradable polyester particles with specific drug targeting and drug release properties J. Pharm. Sci. 97 2008 71 87
4. S.J. McInnes, and N.H. Voelcker Silicon-polymer hybrid materials for drug delivery Future Med. Chem. 1 2009 1051 1074
5. S.S. Hallan, P. Kaur, V. Kaur, N. Mishra, and B. Vaidya Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery Artificial Cells, Nanomed. Biotechnol. 2014 1 16
6. N. Emanuel, Y. Rosenfeld, O. Cohen, Y.H. Applbaum, D. Segal, and Y. Barenholz A lipid-and-polymer-based novel local drug delivery system - BonyPid: from physicochemical aspects to therapy of bacterially infected bones J. Controlled Release: Official J. Controlled Release Soc. 160 2012 353 361
7. A.D. Bangham, M.M. Standish, and N. Miller Cation permeability of phospholipid model membranes: effect of narcotics Nature 208 1965 1295 1297
8. K. Bourzac Nanotechnology: carrying drugs Nature 491 2012 S58 S60
9. S.T. Duggan, and G.M. Keating Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma Drugs 71 2011 2531 2558
10. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 1986 6387 6392
11. G. Berry, M. Billingham, E. Alderman, P. Richardson, F. Torti, B. Lum, A. Patek, and F.J. Martin The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin Ann. Oncol.: Official J. Eur. Soc. Med. Oncol./ESMO 9 1998 711 716
12. M.S. Ewer, F.J. Martin, C. Henderson, C.L. Shapiro, R.S. Benjamin, and A.A. Gabizon Cardiac safety of liposomal anthracyclines Semin. Oncol. 31 2004 161 181
13. R.K. Gieseler, G. Marquitan, M.J. Hahn, L.A. Perdon, W.H. Driessen, S.M. Sullivan, and M.J. Scolaro DC-SIGN-specific liposomal targeting and selective intracellular compound delivery to human myeloid dendritic cells: implications for HIV disease Scand. J. Immunol. 59 2004 415 424
14. H.I. Chang, and M.K. Yeh Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy Int. J. Nanomed. 7 2012 49 60
15. H.S. Choi, W. Liu, P. Misra, E. Tanaka, J.P. Zimmer, B. Itty Ipe, M.G. Bawendi, and J.V. Frangioni Renal clearance of quantum dots Nat. Biotechnol. 25 2007 1165 1170
16. F.C. Szoka Jr., D. Milholland, and M. Barza Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B Antimicrob. Agents Chemother. 31 1987 421 429
17. J. Luczkowiak, S. Sattin, I. Sutkeviciute, J.J. Reina, M. Sanchez-Navarro, M. Thepaut, L. Martinez-Prats, A. Daghetti, F. Fieschi, R. Delgado, A. Bernardi, and J. Rojo Pseudosaccharide functionalized dendrimers as potent inhibitors of DC-SIGN dependent Ebola pseudotyped viral infection Bioconjug. Chem. 22 2011 1354 1365
18. B. Lepenies, J. Lee, and S. Sonkaria Targeting C-type lectin receptors with multivalent carbohydrate ligands Adv. Drug Deliv. Rev. 65 2013 1271 1281
19. H. Hillaireau, and P. Couvreur Nanocarriers' entry into the cell: relevance to drug delivery Cell. Mol. Life Sci.: CMLS 66 2009 2873 2896
20. J. Rejman, V. Oberle, I.S. Zuhorn, and D. Hoekstra Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis Biochem. J. 377 2004 159 169
21. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug Discovery 9 2010 615 627
22. L.M. Bareford, and P.W. Swaan Endocytic mechanisms for targeted drug delivery Adv. Drug Deliv. Rev. 59 2007 748 758
23. A.B. Sipai, V. Yadav, Y. Mamatha, and V. Prasanth Liposomes: an overview J. Pharm. Sci. Innovat. 1 2012
24. S.I. Gringhuis, J. den Dunnen, M. Litjens, M. van der Vlist, and T.B. Geijtenbeek Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori Nat. Immunol. 10 2009 1081 1088
25. A. Aruffo, and B. Seed Expression of cDNA clones encoding the thymocyte antigens CD1a, b, c demonstrates a hierarchy of exclusion in fibroblasts J. Immunol. 143 1989 1723 1730
26. A. Dzionek, Y. Sohma, J. Nagafune, M. Cella, M. Colonna, F. Facchetti, G. Gunther, I. Johnston, A. Lanzavecchia, T. Nagasaka, T. Okada, W. Vermi, G. Winkels, T. Yamamoto, M. Zysk, Y. Yamaguchi, and J. Schmitz BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction J. Exp. Med. 194 2001 1823 1834
27. A. Dzionek, Y. Inagaki, K. Okawa, J. Nagafune, J. Rock, Y. Sohma, G. Winkels, M. Zysk, Y. Yamaguchi, and J. Schmitz Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions Hum. Immunol. 63 2002 1133 1148
28. H. Huang, F. Li, C.M. Cairns, J.R. Gordon, and J. Xiang Neutrophils and B cells express XCR1 receptor and chemotactically respond to lymphotactin Biochem. Biophys. Res. Commun. 281 2001 378 382
29. P.J. Tacken, M. Ter Huurne, R. Torensma, and C.G. Figdor Antibodies and carbohydrate ligands binding to DC-SIGN differentially modulate receptor trafficking Eur. J. Immunol. 42 2012 1989 1998
30. J. Descotes Immunotoxicity of monoclonal antibodies mAbs 1 2009 104 111
31. M. Clark Antibody humanization: a case of the 'Emperor's new clothes'? Immunol. Today 21 2000 397 402
32. C.A. Colaco Towards a unified theory of immunity: dendritic cells, stress proteins and antigen capture Cell. Mol. Biol. 44 1998 883 890
33. S. McNulty, C.A. Colaco, L.E. Blandford, C.R. Bailey, S. Baschieri, and S. Todryk Heat-shock proteins as dendritic cell-targeting vaccines - getting warmer Immunology 139 2013 407 415
34. K.W. Schjetne, K.M. Thompson, N. Nilsen, T.H. Flo, B. Fleckenstein, J.G. Iversen, T. Espevik, and B. Bogen Cutting edge: link between innate and adaptive immunity: toll-like receptor 2 internalizes antigen for presentation to CD4+ T cells and could be an efficient vaccine target J. Immunol. 171 2003 32 36
35. W.I. Weis, M.E. Taylor, and K. Drickamer The C-type lectin superfamily in the immune system Immunol. Rev. 163 1998 19 34
36. E. Pyz, A.S. Marshall, S. Gordon, and G.D. Brown C-type lectin-like receptors on myeloid cells Ann. Med. 38 2006 242 251
37. D. Sancho, and C. Reis e Sousa Sensing of cell death by myeloid C-type lectin receptors Curr. Opin. Immunol. 25 2013 46 52
38. Y. van Kooyk, and G.A. Rabinovich Protein-glycan interactions in the control of innate and adaptive immune responses Nat. Immunol. 9 2008 593 601
39. A.N. Zelensky, and J.E. Gready The C-type lectin-like domain superfamily FEBS J. 272 2005 6179 6217
40. T.B. Geijtenbeek, and S.I. Gringhuis Signalling through C-type lectin receptors: shaping immune responses Nat. Rev. Immunol. 9 2009 465 479
41. J.G. Zhang, P.E. Czabotar, A.N. Policheni, I. Caminschi, S.S. Wan, S. Kitsoulis, K.M. Tullett, A.Y. Robin, R. Brammananth, M.F. van Delft, J. Lu, L.A. O'Reilly, E.C. Josefsson, B.T. Kile, W.J. Chin, J.D. Mintern, M.A. Olshina, W. Wong, J. Baum, M.D. Wright, D.C. Huang, N. Mohandas, R.L. Coppel, P.M. Colman, N.A. Nicola, K. Shortman, and M.H. Lahoud The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments Immunity 36 2012 646 657
42. C.G. Figdor, Y. van Kooyk, and G.J. Adema C-type lectin receptors on dendritic cells and Langerhans cells Nat. Rev. Immunol. 2 2002 77 84
43. R.D. Cummings, and R.P. McEver C-type lectins A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi, G.W. Hart, M.E. Etzler, Essentials of Glycobiology 2009 Cold Spring Harbor NY
44. S.J. van Vliet, E. van Liempt, T.B. Geijtenbeek, and Y. van Kooyk Differential regulation of C-type lectin expression on tolerogenic dendritic cell subsets Immunobiology 211 2006 577 585
45. E.P. McGreal, J.L. Miller, and S. Gordon Ligand recognition by antigen-presenting cell C-type lectin receptors Curr. Opin. Immunol. 17 2005 18 24
46. Y. Chen, S.L. Hwang, V.S. Chan, N.P. Chung, S.R. Wang, Z. Li, J. Ma, C.W. Lin, Y.J. Hsieh, K.P. Chang, S.S. Kung, Y.C. Wu, C.W. Chu, H.T. Tai, G.F. Gao, B. Zheng, K.K. Yokoyama, J.M. Austyn, and C.L. Lin Binding of HIV-1 gp120 to DC-SIGN promotes ASK-1-dependent activation-induced apoptosis of human dendritic cells PLoS Pathog. 9 2013 e1003100
47. H.R. Hensler, M.J. Tomaszewski, G. Rappocciolo, C.R. Rinaldo, and F.J. Jenkins Human herpesvirus 8 glycoprotein B binds the entry receptor DC-SIGN Virus Res. 190 2014 97 103
48. A. Cambi, K. Gijzen, J. de Vries l, R. Torensma, B. Joosten, G.J. Adema, M.G. Netea, B.J. Kullberg, L. Romani, and C.G. Figdor The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells Eur. J. Immunol. 33 2003 532 538
49. N.C. Rogers, E.C. Slack, A.D. Edwards, M.A. Nolte, O. Schulz, E. Schweighoffer, D.L. Williams, S. Gordon, V.L. Tybulewicz, G.D. Brown, and C. Reis e Sousa Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins Immunity 22 2005 507 517
50. S.I. Gringhuis, J. den Dunnen, M. Litjens, B. van Het Hof, Y. van Kooyk, and T.B. Geijtenbeek C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB Immunity 26 2007 605 616
51. S.I. Gringhuis, J. den Dunnen, M. Litjens, M. van der Vlist, B. Wevers, S.C. Bruijns, and T.B. Geijtenbeek Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk Nat. Immunol. 10 2009 203 213
52. T.B. Geijtenbeek, D.S. Kwon, R. Torensma, S.J. van Vliet, G.C. van Duijnhoven, J. Middel, I.L. Cornelissen, H.S. Nottet, V.N. KewalRamani, D.R. Littman, C.G. Figdor, and Y. van Kooyk DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells Cell 100 2000 587 597
53. S.G. Turville, J. Arthos, K.M. Donald, G. Lynch, H. Naif, G. Clark, D. Hart, and A.L. Cunningham HIV gp120 receptors on human dendritic cells Blood 98 2001 2482 2488
54. S.F. Wang, J.C. Huang, Y.M. Lee, S.J. Liu, Y.J. Chan, Y.P. Chau, P. Chong, and Y.M. Chen DC-SIGN mediates avian H5N1 influenza virus infection in cis and in trans Biochem. Biophys. Res. Commun. 373 2008 561 566
55. B. Tassaneetrithep, T.H. Burgess, A. Granelli-Piperno, C. Trumpfheller, J. Finke, W. Sun, M.A. Eller, K. Pattanapanyasat, S. Sarasombath, D.L. Birx, R.M. Steinman, S. Schlesinger, and M.A. Marovich DC-SIGN (CD209) mediates Dengue virus infection of human dendritic cells J. Exp. Med. 197 2003 823 829
56. M.K. Richter, J.M. Da Silva Voorham, S. Torres Pedraza, T.E. Hoornweg, D.P. van de Pol, I.A. Rodenhuis-Zybert, J. Wilschut, and J.M. Smit Immature Dengue virus is infectious in human immature dendritic cells via interaction with the receptor molecule DC-SIGN PloS One 9 2014 e98785
57. A. Marzi, P. Moller, S.L. Hanna, T. Harrer, J. Eisemann, A. Steinkasserer, S. Becker, F. Baribaud, and S. Pohlmann Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR J. Infect. Dis. 196 Suppl. 2 2007 S237 S246
58. N. Varga, I. Sutkeviciute, R. Ribeiro-Viana, A. Berzi, R. Ramdasi, A. Daghetti, G. Vettoretti, A. Amara, M. Clerici, J. Rojo, F. Fieschi, and A. Bernardi A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus Biomaterials 35 2014 4175 4184
59. J.J. Garcia-Vallejo, N. Koning, M. Ambrosini, H. Kalay, I. Vuist, R. Sarrami-Forooshani, T.B. Geijtenbeek, and Y. van Kooyk Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells Int. Immunol. 25 2013 221 233
60. M. Anderluh, G. Jug, U. Svajger, and N. Obermajer DC-SIGN antagonists, a potential new class of anti-infectives Curr. Med. Chem. 19 2012 992 1007
61. R. Ribeiro-Viana, M. Sanchez-Navarro, J. Luczkowiak, J.R. Koeppe, R. Delgado, J. Rojo, and B.G. Davis Virus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infection Nat. Commun. 3 2012 1303
62. P. Stahl, P.H. Schlesinger, E. Sigardson, J.S. Rodman, and Y.C. Lee Receptor-mediated pinocytosis of mannose glycoconjugates by macrophages: characterization and evidence for receptor recycling Cell 19 1980 207 215
63. A.J. Engering, M. Cella, D.M. Fluitsma, E.C. Hoefsmit, A. Lanzavecchia, and J. Pieters Mannose receptor mediated antigen uptake and presentation in human dendritic cells Adv. Exp. Med. Biol. 417 1997 183 187
64. K. Mahnke, M. Guo, S. Lee, H. Sepulveda, S.L. Swain, M. Nussenzweig, and R.M. Steinman The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments J. Cell Biol. 151 2000 673 684
65. A. Engering, T.B. Geijtenbeek, S.J. van Vliet, M. Wijers, E. van Liempt, N. Demaurex, A. Lanzavecchia, J. Fransen, C.G. Figdor, V. Piguet, and Y. van Kooyk The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells J. Immunol. 168 2002 2118 2126
66. W.W. Unger, A.J. van Beelen, S.C. Bruijns, M. Joshi, C.M. Fehres, L. van Bloois, M.I. Verstege, M. Ambrosini, H. Kalay, K. Nazmi, J.G. Bolscher, E. Hooijberg, T.D. de Gruijl, G. Storm, and Y. van Kooyk Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells J. Controlled Release: Official J. Controlled Release Soc. 160 2012 88 95
67. Y. van Kooyk, W.W. Unger, C.M. Fehres, H. Kalay, and J.J. Garcia-Vallejo Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation Mol. Immunol. 55 2013 143 145
68. R.W. Carter, C. Thompson, D.M. Reid, S.Y. Wong, and D.F. Tough Induction of CD8+ T cell responses through targeting of antigen to Dectin-2 Cell. Immunol. 239 2006 87 91
69. R.W. Carter, C. Thompson, D.M. Reid, S.Y. Wong, and D.F. Tough Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1 J. Immunol. 177 2006 2276 2284
70. L. Bozzacco, C. Trumpfheller, F.P. Siegal, S. Mehandru, M. Markowitz, M. Carrington, M.C. Nussenzweig, A.G. Piperno, and R.M. Steinman DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes Proc. Natl. Acad. Sci. USA 104 2007 1289 1294
71. D. Dudziak, A.O. Kamphorst, G.F. Heidkamp, V.R. Buchholz, C. Trumpfheller, S. Yamazaki, C. Cheong, K. Liu, H.W. Lee, C.G. Park, R.M. Steinman, and M.C. Nussenzweig Differential antigen processing by dendritic cell subsets in vivo Science 315 2007 107 111
72. D. Sancho, O.P. Joffre, A.M. Keller, N.C. Rogers, D. Martinez, P. Hernanz-Falcon, I. Rosewell, and C. Reis e Sousa Identification of a dendritic cell receptor that couples sensing of necrosis to immunity Nature 458 2009 899 903
73. I. Eue Differential uptake of conventional and polyethylene glycol modified-alkylphosphocholine-liposomes by J 774A.1 murine macrophages Drug Delivery 5 1998 265 273
74. A. D'Avolio, D. Pensi, L. Baietto, and G. Di Perri Therapeutic drug monitoring of intracellular anti-infective agents J. Pharm. Biomed. Anal. 2014